You are here
GENAERA CORPORATION
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Aminosterols as Anti-angiogenic Therapeutics for AMD
Amount: $100,000.00Age-related macular degeneration (AMD) is a public health problem resulting in the loss of independence in a significant number of the elderly population. The most severe form of AMD, wet AMD, is caus ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
Aminosterol MSI-1436 as a Therapeutic for Obesity
Amount: $100,000.00DESCRIPTION (provided by applicant): Obesity is a disease that has increased at an alarming rate. Today, 64.5 percent of adult Americans (about 127 million) are categorized as being overweight (body m ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health -
AMINOSTEROL COMPOUNDS AS THERAPEUTIC FOR ASTHMA
Amount: $0.00DESCRIPTION (provided by applicant):Phase II research will emphasize continuing in vitro and in vivo data collection to identify Genaera aminosterol library compounds useful in treating a ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
AMINOSTEROL COMPOUNDS AS THERAPEUTIC FOR ASTHMA
Amount: $796,186.00DESCRIPTION (provided by applicant):Phase II research will emphasize continuing in vitro and in vivo data collection to identify Genaera aminosterol library compounds useful in treating a ...
SBIRPhase II2002Department of Health and Human Services National Institutes of Health -
N/A
Amount: $100,000.00N/A
SBIRPhase I2000Department of Health and Human Services National Institutes of Health -
MANUFACTURING DEVELOPMENT FOR SQUALAMINE LACTATE
Amount: $105,610.00Not Available There exists a need within the military and civilian sectors for a system that marries the best qualities of an underwater SLR camera with a camcorder. The IEM system will possess the c ...
SBIRPhase I1999Department of Health and Human Services -
NOVEL MAGAIN DRUGS FOR PSEUDOMEMBRANOUS COLITIS
Amount: $500,000.00THE LONG-RANGE OBJECTIVES OF THIS PROJECT ARE TO (1) IDENTIFY NOVEL DRUG CANDIDATES RELATED TO THE MAGAININ CLASSOF PEPTIDES WITH POTENTIAL ANTIBACTERIAL, ANTIVIRAL, AND ANTI-INFLAMMATORY ACTIVITY THA ...
SBIRPhase II1991Department of Health and Human Services -
MAGAININS' ROLE IN INHIBITING ORAL FLORA AND SYNERGY EFFECTS
Amount: $50,000.00THE LONG-TERM OBJECTIVES OF THIS PROJECT ARE TO (1) IDENTIFYNOVEL DRUG CANDIDATES RELATED TO THE MAGAININ PEPTIDE CLASS WITH POWERFUL ANTI-INFECTIVE ACTIVITY AGAINST PATHOGENIC ORAL CAVITY FLORA, (2) ...
SBIRPhase I1990Department of Health and Human Services -
NOVEL MAGAIN DRUGS FOR PSEUDOMEMBRANOUS COLITIS
Amount: $50,000.00N/A
SBIRPhase I1989Department of Health and Human Services